Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 21, 2019 (7 years ago)

Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief (Capsaicin 0.2%) Topical Analgesic Cream, 4 OZ (113.4 g) bottle with pump, Distributed by: Coast to Coast Natural, Inc., Wellington, FL 33414, NDC 63788-120-04.

Affected NDC 63788-0120-04

Compare with the code on your package — it is the most precise check available.

Drug: Capsaicin

Recalling firm
Pharma-Natural Inc.
NDC code
63788-120-04
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1492-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Capsaicin recalls

See all
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0529-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0527-2024

Other recalls by Pharma-Natural Inc.

All 2019 recalls
Class II · Moderate risk

Workvie Instant Pain Relieving Roll On

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 72393-201-25 D-1507-2019
Class II · Moderate risk

Neogen-D

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-699-16 D-1506-2019
Class II · Moderate risk

Sorbugen Nr

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-660-16 D-1505-2019
Class II · Moderate risk

Tusslin

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-622-16 D-1504-2019